ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI, cilt.46, sa.3, ss.1009-1029, 2022 (Scopus)
Objective: Today, cancer is still among
the most common chronic diseases. Nanoparticular drug delivery systems prepared
with biocompatible and biodegradable polymers such as polycaprolactone are
rational solution for anticancer agents with poor solubility and low bioavailability.
The aim of this study is to prepare paclitaxel-loaded polycaprolactone
nanoparticles, which is known to be a potent anticancer, and to elucidate in
vitro characteristics and release kinetic mechanisms.
Material
and Method: It was aimed to prepare paclitaxel-loaded
polycaprolactone nanoparticles by nanoprecipitation. Preformulation studies were
carried out with different molecular weights of polycaprolactone (Mw: 14.000, Mw:
80.000). Nanoparticles were coated with Chitosan or Poly-l-lysine to obtain
cationic surface charge and to increase cellular interaction. Comprehensive characterization
of formulations and release kinetic studies were performed.
Result
and Discussion: The particle size of the formulations ranged
from 188 nm to 383 nm. Encapsulation efficiency increased to 77% in different
formulations. SEM analysis confirmed the nanoparticles were spherical. Within
the scope of in vitro release studies, the release continued for up to 96 hours
and less than 50% of the therapeutic load was released in the first 24 hours. Mathematical
modeling indicated that the release kinetics fit more than one model with the
Korsmeyer-Peppas, Peppas-Sahlin and Weibull models, which show high
correlation.